Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 3, 2006, Pages 355-360

  Yu, Lei ^a   Sloane, Dana A ^a   Guo, Chuanfa ^a   Howell, Charles D ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER REGISTRY; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; EUROPEAN AMERICAN; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOSPITAL PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 33644764668     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2005.12.022     Document Type: Article

References (25)

1. H.B. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
2. H.B. El-Serag, J.A. Davila, N.J. Petersen The continuing increase in the incidence of hepatocellular carcinoma in the United States an update Ann Intern Med 139 2003 817 823
3. H.B. El-Serag, A.C. Mason Risk factors for the rising rates of primary liver cancer in the United States Arch Intern Med 160 2000 3227 3230
4. J.A. Davila, R.O. Morgan, Y. Shaib Hepatitis C infection and the increasing incidence of hepatocellular carcinoma a population-based study Gastroenterology 127 2004 1372 1380
5. A.M. Di Bisceglie, A.C. Lyra, M. Schwartz Hepatitis C-related hepatocellular carcinoma in the United States influence of ethnic status Am J Gastroenterol 98 2003 2060 2063
6. C. Steiner, A. Elixhauser, J. Schnaier The healthcare cost and utilization project an overview Eff Clin Pract 5 2002 143 151
7. A. Darbari, K.M. Sabin, C.N. Shapiro Epidemiology of primary hepatic malignancies in U.S. children Hepatology 38 2003 560 566
8. M.M. Hassan, L.Y. Hwang, C.J. Hatten Risk factors for hepatocellular carcinoma synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 2002 1206 1213
9. H.B. El-Serag, P.A. Richardson, J.E. Everhart The role of diabetes in hepatocellular carcinoma a case-control study among United States Veterans Am J Gastroenterol 96 2001 2462 2467
10. G.D. Kirk, O.A. Lesi, M. Mendy The Gambia Liver Cancer Study infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa Hepatology 39 2004 211 219
11. M.J. Alter, D. Kruszon-Moran, O.V. Nainan The prevalence of hepatitis C infection in the United States, 1988 through 1999 N Engl J Med 341 1999 556 562
12. G.L. Armstrong, E.P. Simard, A. Wasley The prevalence of hepatitis C infection in the United States, 1999-2002 Hepatology 40 2004 176A
13. J.M. Yuan, S. Govindarajan, K. Arakawa Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S Cancer 101 2004 1009 1017
14. J.A. Davila, R.O. Morgan, Y. Shaib Diabetes increases the risk of hepatocellular carcinoma in the United States a population based case control study Gut 54 2005 533 539
15. S. Nair, A. Mason, J. Eason Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36 2002 150 155
16. E. Bugianesi, N. Leone, E. Vanni Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
17. J.A. Marrero, R.J. Fontana, G.L. Su NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
18. CDC Acute hepatitis B among children and adolescents - United States, 1990-2002 MMWR Morb Mortal Wkly Rep 53 2004 1015 1018
19. C.R. Baquet, J.W. Horm, T. Gibbs Socioeconomic factors and cancer incidence among blacks and whites J Natl Cancer Inst 83 1991 551 557
20. CDC Achievements in public health hepatitis B vaccination United States, 1982-2002 MMWR Morb Mortal Wkly Rep 51 2002 549 552
21. Y.F. Liaw, J.J. Sung, W.C. Chow Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
22. Y. Shiratori, Y. Ito, O. Yokosuka Antiviral therapy for cirrhotic hepatitis C association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 2005 105 114
23. K. Soga, K. Shibasaki, Y. Aoyagi Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C Hepatogastroenterology 52 2005 1154 1158
24. A.J. Muir, J.D. Bornstein, P.G. Killenberg Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-hispanic whites N Engl J Med 350 2004 2265 2271
25. L.J. Jeffers, W. Cassidy, C.D. Howell Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1 Hepatology 39 2004 1702 1708